RNA biomarkers in colorectal cancer. (Q54286948)

27 May 2018

title

RNA biomarkers in colorectal cancer. (English)

1 reference

27 May 2018

0 references

1 reference

1

1 reference

27 May 2018

author name string

Jamie Murphy

series ordinal

2

1 reference

27 May 2018

publication date

16 October 2012

1 reference

27 May 2018

published in

Methods

1 reference

27 May 2018

volume

59

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

116-125

1 reference

27 May 2018

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Prognostic factors in colorectal cancer. Literature review for clinical application.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Challenges in the management of stage II colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Randomised trials of HIV prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Rethinking the metastatic cascade as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Colorectal cancer molecular biology moves into clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNAs as Biomarkers in Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Predictive biomarkers: a paradigm shift towards personalized cancer medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Predictive and prognostic markers in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Biomarker-based selection of therapy for colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Contrasting US and European approaches to colorectal cancer screening: which is best?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Synchronous colorectal cancers: a review of clinical features, diagnosis, treatment, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Screening for colorectal cancer: established and emerging modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Human stools as a source of viable colonic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Exfoliated cells in stool: a source for reverse transcription-PCR-based analysis of biomarkers of gastrointestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Fecal Tests: From Blood to Molecular Markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Circulating tumour cell detection on its way to routine diagnostic implementation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood--a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular signature detection of circulating tumor cells using a panel of selected genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Epithelial molecular markers in the peripheral blood of patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

The clinical significance of circulating tumor cells in non-metastatic colorectal cancer--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Circulating tumor cells in gastrointestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Circulating tumor cells in colorectal cancer: past, present, and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Implementing prognostic and predictive biomarkers in CRC clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular biology for stage II colorectal cancer: the jury is still out

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Gene selection and classification of microarray data using random forest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

cDNA array analysis for prediction of hepatic metastasis of colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Alternative spliced variants as biomarkers of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Overexpression of BDNF and TrkB in human bladder cancer specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Prognostic markers of local relapse in rectal cancer: are we any further forward?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNA: future perspectives in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNA profiling differentiates colorectal cancer according to KRAS status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Plasma microRNAs: a potential biomarker for colorectal cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Fecal MicroRNAs as novel biomarkers for colon cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular medicine, gene-expression profiling and molecular diagnostics: putting the cart before the horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular prognostic markers in locally advanced colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Genetic associations in large versus small studies: an empirical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Statistical considerations for the next generation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular prognostics in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Predictive markers of colorectal cancer liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Clinical biomarkers in oncology: focus on colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Why and how do journals retract articles? An analysis of Medline retractions 1988-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Retractions in the scientific literature: is the incidence of research fraud increasing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Retractions in the scientific literature: do authors deliberately commit research fraud?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Retracted science and the retraction index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Do rebuttals affect future science?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Why the need for qPCR publication guidelines?--The case for MIQE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Stochastic mRNA synthesis in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Living with noisy genes: how cells function reliably with inherent variability in gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Noise in gene expression: origins, consequences, and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Role of cancer microenvironment in metastasis: focus on colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A molecular signature of metastasis in primary solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Variations in stromal signatures in breast and colorectal cancer metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Genome-wide analysis of alternative pre-mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Pre-mRNA splicing aberrations and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

15000 unique zebrafish EST clusters and their future use in microarray for profiling gene expression patterns during embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Evolution and functions of long noncoding RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

The dynamic landscapes of RNA architecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Towards sound epistemological foundations of statistical methods for high-dimensional biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Quantification of mRNA in single cells and modelling of RT-qPCR induced noise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Stochastic modelling for quantitative description of heterogeneous biological systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Germ line polymorphism in metastatic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Nucleic acid quantification and disease outcome prediction in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Transcriptional profiling of tissue plasticity: role of shifts in gene expression and technical limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Feature selection and molecular classification of cancer using genetic programming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

The value of microarray techniques for quantitative gene profiling in molecular diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Integrative analysis of multiple gene expression profiles applied to liver cancer study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Identifying biological themes within lists of genes with EASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Differential coexpression analysis using microarray data and its application to human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Molecular staging of colorectal cancer: new paradigm or waste of time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Quantification using real-time PCR technology: applications and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Primer sequence disclosure: a clarification of the MIQE guidelines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.10.003

10.1016/J.YMETH.2012.10.003

7 January 2021

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018